Jasper Therapeutics, Inc.
JSPR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $5.05M in total; no superinvestor holds it.
Other share classesJSPRW
13F holders, Q1 2024
Institutional positions in Jasper Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 61
- +19 vs. Q4 2023
- Shares held
- 13.0M
- −62.5M (−82.7%) vs. Q4 2023
- Total value
- $380.2M
- +$319.0M (+521.3%) vs. Q4 2023
- New holders
- 33
- 2 more added
- Sold out
- 14
- 26 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JSPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $5.05M |
| Q1 2026 | 58 | $13.9M |
| Q4 2025 | 55 | $35.2M |
| Q3 2025 | 60 | $47.8M |
| Q2 2025 | 65 | $69.5M |
| Q1 2025 | 69 | $56.1M |
| Q4 2024 | 88 | $334.5M |
| Q3 2024 | 81 | $274.8M |
| Q2 2024 | 69 | $329.8M |
| Q1 2024 | 61 | $380.2M |
| Q4 2023 | 42 | $61.2M |
| Q3 2023 | 41 | $63.7M |
| Q2 2023 | 46 | $120.0M |
| Q1 2023 | 45 | $168.8M |
| Q4 2022 | 23 | $9.57M |
| Q3 2022 | 23 | $15.7M |
| Q2 2022 | 23 | $37.5M |
| Q1 2022 | 24 | $69.6M |
| Q4 2021 | 25 | $160.7M |
| Q3 2021 | 9 | $101.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Jasper Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Velan Capital Investment Management LP | 1,471,904 | $42.1M | 22.76% | −9,747,132−86.9% | Reduced |
| Soleus Capital Management, L.P. | 1,187,096 | $34.9M | 3.06% | −8,683,884−88.0% | Reduced |
| Carlyle Group Inc. | 1,066,189 | $31.3M | 1.97% | −7,695,702−87.8% | Reduced |
| Qiming U.S. Ventures Management, LLC | 928,964 | $27.3M | 30.41% | −7,590,684−89.1% | Reduced |
| Avidity Partners Management LP | 760,000 | $22.3M | 0.79% | +760,000 | New |
| Franklin Resources Inc | 722,074 | $21.2M | 0.01% | +722,074 | New |
| Vanguard Group Inc | 612,745 | $18.0M | 0.00% | −3,480,213−85.0% | Reduced |
| Samsara BioCapital, LLC | 525,000 | $15.4M | 2.38% | +525,000 | New |
| Sphera Funds Management Ltd. | 505,242 | $14.8M | 2.40% | −207,821−29.1% | Reduced |
| Octagon Capital Advisors LP | 500,811 | $14.7M | 1.79% | −3,967,303−88.8% | Reduced |
| Kingdon Capital Management, L.L.C. | 497,000 | $14.6M | 1.93% | −3,043,000−86.0% | Reduced |
| Opaleye Management Inc. | 435,573 | $12.8M | 2.79% | −3,549,767−89.1% | Reduced |
| Great Point Partners LLC | 407,550 | $12.0M | 1.86% | +407,550 | New |
| Rock Springs Capital Management LP | 404,335 | $11.9M | 0.30% | +404,335 | New |
| Woodline Partners LP | 379,246 | $11.1M | 0.10% | −1,353,747−78.1% | Reduced |
| Boxer Capital, LLC | 350,000 | $10.3M | 0.51% | +350,000 | New |
| Bank of America Corp | 319,787 | $9.39M | 0.00% | −2,860,272−89.9% | Reduced |
| Ally Bridge Group (NY) LLC | 289,943 | $8.51M | 4.73% | −3,369,312−92.1% | Reduced |
| BlackRock Inc. | 193,422 | $5.68M | 0.00% | −1,130,550−85.4% | Reduced |
| Morgan Stanley | 176,417 | $5.18M | 0.00% | −1,523,133−89.6% | Reduced |
| StemPoint Capital LP | 129,211 | $3.79M | 1.01% | +129,211 | New |
| Geode Capital Management, LLC | 127,991 | $3.76M | 0.00% | −776,486−85.8% | Reduced |
| Millennium Management LLC | 111,366 | $3.27M | 0.00% | −18,517−14.3% | Reduced |
| Silverarc Capital Management, LLC | 109,892 | $3.23M | 0.90% | +109,892 | New |
| Ikarian Capital, LLC | 105,175 | $3.09M | 0.84% | +105,175 | New |
| Russell Investments Group, Ltd. | 79,811 | $2.34M | 0.00% | +79,811 | New |
| Mariner, LLC | 52,826 | $1.55M | 0.00% | −537,684−91.1% | Reduced |
| Fernwood Investment Management, LLC | 49,470 | $1.45M | 0.42% | −445,236−90.0% | Reduced |
| LMR Partners LLP | 43,945 | $1.29M | 0.03% | +43,945 | New |
| Jane Street Group, LLC | 41,894 | $1.23M | 0.00% | +30,685+273.8% | Added |
| State Street Corp | 39,999 | $1.17M | 0.00% | −189,995−82.6% | Reduced |
| Cantor Fitzgerald, L. P. | 35,000 | $1.05M | 0.25% | +35,000 | New |
| Lion Point Capital, LP | 32,000 | $939.5K | 1.80% | +32,000 | New |
| Bank of Montreal | 69,100 | $811.9K | 0.00% | −279,200−80.2% | Reduced |
| Boothbay Fund Management, LLC | 23,324 | $684.8K | 0.02% | +23,324 | New |
| HRT Financial LP | 23,271 | $683.0K | 0.00% | +23,271 | New |
| Northern Trust Corp | 22,697 | $666.4K | 0.00% | −132,212−85.3% | Reduced |
| EAM Investors, LLC | 21,525 | $632.0K | 0.10% | +21,525 | New |
| Concurrent Investment Advisors, LLC | 20,409 | $599.2K | 0.02% | +20,409 | New |
| Man Group plc | 20,357 | $597.7K | 0.00% | +20,357 | New |
| Citadel Advisors LLC | 16,210 | $475.9K | 0.00% | −174,945−91.5% | Reduced |
| Marshall Wace, LLP | 13,449 | $394.9K | 0.00% | +13,449 | New |
| Landscape Capital Management, L.L.C. | 11,397 | $334.6K | 0.03% | −777,934−98.6% | Reduced |
| American Century Companies Inc | 11,172 | $328.0K | 0.00% | +11,172 | New |
| Virtu Financial LLC | 10,410 | $306.0K | 0.02% | +10,410 | New |
| Cubist Systematic Strategies, LLC | 10,250 | $300.9K | 0.00% | +10,250 | New |
| Balyasny Asset Management LLC | 8,417 | $247.1K | 0.00% | +8,417 | New |
| Brevan Howard Capital Management LP | 8,378 | $246.0K | 0.02% | +8,378 | New |
| Susquehanna International Group, LLP | 8,084 | $237.3K | 0.00% | +8,084 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 8,002 | $234.9K | 0.06% | +8,002 | New |
| Leonteq Securities AG | 8,000 | $234.9K | 0.03% | +8,000 | New |
| Atom Investors LP | 7,373 | $216.5K | 0.03% | +7,373 | New |
| Citigroup Inc | 7,363 | $216.2K | 0.00% | +7,363 | New |
| Simplex Trading, LLC | 3,758 | $110.0K | 0.00% | +3,732+14,353.8% | Added |
| ADAR1 Capital Management, LLC | 2,406 | $70.6K | 0.02% | +2,406 | New |
| Lazard Asset Management LLC | 744 | $21.0K | 0.00% | −10,756−93.5% | Reduced |
| Wells Fargo & Company | 92 | $2.70K | 0.00% | −517−84.9% | Reduced |
| National Bank of Canada | 100 | $2.12K | 0.00% | +100 | New |
| BFSG, LLC | 10 | $294 | 0.00% | +10 | New |
| Macquarie Group Ltd | 697 | $20 | 0.00% | +697 | New |
| Royal Bank of Canada | 10 | $0 | 0.00% | −247−96.1% | Reduced |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −2,228,265−100.0% | Sold out |
| Saturn V Capital Management LLC | 0 | $0 | 0.00% | −1,386,215−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −514,324−100.0% | Sold out |
| Monaco Asset Management SAM | 0 | $0 | 0.00% | −249,563−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Summit Trail Advisors, LLC | 0 | $0 | 0.00% | −65,000−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −54,500−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −54,168−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −43,593−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −36,899−100.0% | Sold out |
| Gries Financial LLC | 0 | $0 | 0.00% | −23,845−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −11,144−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |